BRPI1008941A2 - Sequência polinucleotídica e polipeptídica e métodos da mesma. - Google Patents

Sequência polinucleotídica e polipeptídica e métodos da mesma.

Info

Publication number
BRPI1008941A2
BRPI1008941A2 BRPI1008941-1A BRPI1008941A BRPI1008941A2 BR PI1008941 A2 BRPI1008941 A2 BR PI1008941A2 BR PI1008941 A BRPI1008941 A BR PI1008941A BR PI1008941 A2 BRPI1008941 A2 BR PI1008941A2
Authority
BR
Brazil
Prior art keywords
polynucleotide
methods
polypeptide sequence
polypeptide
sequence
Prior art date
Application number
BRPI1008941-1A
Other languages
English (en)
Inventor
Mulakkapurath Narayanan Manoj
Venkata Ramachandra Rao Vasamsetty
Madhuri Baliga
Kirubakaran Naveen Kumar
Chandrasekhar Bhaskaran Nair
Pillarisetti Venkata Subbarao
Original Assignee
Bigtec Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bigtec Private Ltd filed Critical Bigtec Private Ltd
Publication of BRPI1008941A2 publication Critical patent/BRPI1008941A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1008941-1A 2009-03-12 2010-03-12 Sequência polinucleotídica e polipeptídica e métodos da mesma. BRPI1008941A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN567CH2009 2009-03-12
PCT/IN2010/000144 WO2010103546A2 (en) 2009-03-12 2010-03-12 A polynucleotide and polypeptide sequence and methods thereof

Publications (1)

Publication Number Publication Date
BRPI1008941A2 true BRPI1008941A2 (pt) 2015-09-01

Family

ID=42728894

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008941-1A BRPI1008941A2 (pt) 2009-03-12 2010-03-12 Sequência polinucleotídica e polipeptídica e métodos da mesma.

Country Status (11)

Country Link
US (3) US8575322B2 (pt)
EP (1) EP2406377B1 (pt)
KR (1) KR101702342B1 (pt)
CN (1) CN102439154A (pt)
AU (1) AU2010223154B2 (pt)
BR (1) BRPI1008941A2 (pt)
CA (1) CA2755300A1 (pt)
MY (1) MY161552A (pt)
SG (1) SG174313A1 (pt)
WO (1) WO2010103546A2 (pt)
ZA (1) ZA201107067B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9223951B2 (en) 2014-02-07 2015-12-29 Bank Of America Corporation User authentication based on other applications
US9286450B2 (en) 2014-02-07 2016-03-15 Bank Of America Corporation Self-selected user access based on specific authentication types
US9647999B2 (en) 2014-02-07 2017-05-09 Bank Of America Corporation Authentication level of function bucket based on circumstances
US9208301B2 (en) 2014-02-07 2015-12-08 Bank Of America Corporation Determining user authentication requirements based on the current location of the user in comparison to the users's normal boundary of location
US9721268B2 (en) 2014-03-04 2017-08-01 Bank Of America Corporation Providing offers associated with payment credentials authenticated in a specific digital wallet
US9729536B2 (en) 2015-10-30 2017-08-08 Bank Of America Corporation Tiered identification federated authentication network system
US10511692B2 (en) 2017-06-22 2019-12-17 Bank Of America Corporation Data transmission to a networked resource based on contextual information
US10524165B2 (en) 2017-06-22 2019-12-31 Bank Of America Corporation Dynamic utilization of alternative resources based on token association
US10313480B2 (en) 2017-06-22 2019-06-04 Bank Of America Corporation Data transmission between networked resources
CN111094572B (zh) * 2018-02-09 2023-04-04 江苏恒瑞医药股份有限公司 一种密码子优化的人胰岛素类似物前体基因和信号肽基因
EP3805257A4 (en) * 2018-05-24 2022-03-16 Jiangsu Hengrui Medicine Co., Ltd. METHOD OF PRODUCTION OF A PRECURSOR OF RECOMBINANT HUMAN INSULIN OR ANALOGUE THEREOF
US10799564B1 (en) 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same
CN115634473B (zh) * 2022-03-09 2026-04-03 中国人民解放军海军军医大学 一种膜蛋白原位合成亲和生物色谱柱及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
US6251856B1 (en) * 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
AU2149899A (en) * 1998-01-23 1999-08-09 Novo Nordisk A/S Process for making desired polypeptides in yeast
FR2810339B1 (fr) * 2000-06-14 2004-12-10 Hoechst Marion Roussel Inc Banques combinatoires ameliorees par recombinaison dans la levure et procede d'analyse
WO2008134996A1 (de) * 2007-05-03 2008-11-13 Siemens Aktiengesellschaft Verfahren zum beeinflussen von einrichtungen einer hochspannungsanlage
WO2008139496A1 (en) * 2007-05-16 2008-11-20 Bigtec Private Limited Recombinant human insulin and a method thereof

Also Published As

Publication number Publication date
US8575322B2 (en) 2013-11-05
AU2010223154B2 (en) 2014-10-09
SG174313A1 (en) 2011-10-28
KR20110132447A (ko) 2011-12-07
US20120077966A1 (en) 2012-03-29
EP2406377A4 (en) 2012-12-26
CN102439154A (zh) 2012-05-02
EP2406377A2 (en) 2012-01-18
ZA201107067B (en) 2012-05-30
KR101702342B1 (ko) 2017-02-03
US9309281B2 (en) 2016-04-12
AU2010223154A1 (en) 2011-10-13
WO2010103546A2 (en) 2010-09-16
MY161552A (en) 2017-04-28
WO2010103546A3 (en) 2011-01-06
US20140051842A1 (en) 2014-02-20
US20140057318A1 (en) 2014-02-27
CA2755300A1 (en) 2010-09-16
US9238674B2 (en) 2016-01-19
EP2406377B1 (en) 2016-01-06

Similar Documents

Publication Publication Date Title
BRPI1008941A2 (pt) Sequência polinucleotídica e polipeptídica e métodos da mesma.
BRPI1010301A2 (pt) composição.
HUE036081T2 (hu) Mirac proteinek
HUE032929T2 (hu) Bifunkcionális polipeptidek
BRPI1016079A2 (pt) escaneamento antivírus.
BRPI1008709A2 (pt) composições e usos das mesmas.
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
PT2464370T (pt) Péptidos vasoativos intestinais modificados
BR112012000281A2 (pt) proteína quimérica.
BR112012002877A2 (pt) dilatador e conjunto.
IT1396487B1 (it) Convogliatore.
BRPI1010661A2 (pt) peptídeo
DK2391893T3 (da) Lyofiliseret dabigatran
BR112012002612A2 (pt) calha.
BR112012000565A2 (pt) ensaio de vírus.
BRPI1008596A2 (pt) sistema, e, aparelho
FR2942385B1 (fr) Grille-pain.
BR112012003860A2 (pt) Combinação, e, composição nutricional
IT1395137B1 (it) Nuovi peptidi antipatogeni
FR2944701B1 (fr) Composition coloree.
FR2943510B1 (fr) Ombrelle.
BR112012000911A2 (pt) biomarcador.
ES1071381Y (es) Jamonero basculante
ITRM20090257A1 (it) Trocar.
BRPI1006779A2 (pt) polipeptídeo isolado, polinucleotídeo isolado,método de isolamento de polipeptídeo e preparação.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2505 DE 08-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.